Cargando…

Hepatitis E in blood donors: investigation of the natural course of asymptomatic infection, Germany, 2011

Asymptomatic hepatitis E virus (HEV) infections have been found in blood donors from various European countries, but the natural course is rarely specified. Here, we compared the progression of HEV viraemia, serostatus and liver-specific enzymes in 10 blood donors with clinically asymptomatic genoty...

Descripción completa

Detalles Bibliográficos
Autores principales: Vollmer, Tanja, Diekmann, Juergen, Eberhardt, Matthias, Knabbe, Cornelius, Dreier, Jens
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Centre for Disease Prevention and Control (ECDC) 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5015460/
https://www.ncbi.nlm.nih.gov/pubmed/27608433
http://dx.doi.org/10.2807/1560-7917.ES.2016.21.35.30332
_version_ 1782452442979368960
author Vollmer, Tanja
Diekmann, Juergen
Eberhardt, Matthias
Knabbe, Cornelius
Dreier, Jens
author_facet Vollmer, Tanja
Diekmann, Juergen
Eberhardt, Matthias
Knabbe, Cornelius
Dreier, Jens
author_sort Vollmer, Tanja
collection PubMed
description Asymptomatic hepatitis E virus (HEV) infections have been found in blood donors from various European countries, but the natural course is rarely specified. Here, we compared the progression of HEV viraemia, serostatus and liver-specific enzymes in 10 blood donors with clinically asymptomatic genotype 3 HEV infection, measuring HEV RNA concentrations, plasma concentrations of alanine/aspartate aminotransferase, glutamate dehydrogenase and bilirubin and anti-HEV IgA, IgM and IgG antibodies. RNA concentrations ranged from 77.2 to 2.19×10(5) IU/mL, with viraemia lasting from less than 10 to 52 days. Donors showed a typical progression of a recent HEV infection but differed in the first detection of anti-HEV IgA, IgM and IgG and seropositivity of the antibody classes. The diagnostic window between HEV RNA detection and first occurrence of anti-HEV antibodies ranged from eight to 48 days, depending on the serological assay used. The progression of laboratory parameters of asymptomatic HEV infection was largely comparable to the progression of symptomatic HEV infection, but only four of 10 donors showed elevated liver-specific parameters. Our results help elucidate the risk of transfusion-associated HEV infection and provide a basis for development of screening strategies. The diagnostic window illustrates that infectious blood donors can be efficiently identified only by RNA screening.
format Online
Article
Text
id pubmed-5015460
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher European Centre for Disease Prevention and Control (ECDC)
record_format MEDLINE/PubMed
spelling pubmed-50154602016-09-28 Hepatitis E in blood donors: investigation of the natural course of asymptomatic infection, Germany, 2011 Vollmer, Tanja Diekmann, Juergen Eberhardt, Matthias Knabbe, Cornelius Dreier, Jens Euro Surveill Research Article Asymptomatic hepatitis E virus (HEV) infections have been found in blood donors from various European countries, but the natural course is rarely specified. Here, we compared the progression of HEV viraemia, serostatus and liver-specific enzymes in 10 blood donors with clinically asymptomatic genotype 3 HEV infection, measuring HEV RNA concentrations, plasma concentrations of alanine/aspartate aminotransferase, glutamate dehydrogenase and bilirubin and anti-HEV IgA, IgM and IgG antibodies. RNA concentrations ranged from 77.2 to 2.19×10(5) IU/mL, with viraemia lasting from less than 10 to 52 days. Donors showed a typical progression of a recent HEV infection but differed in the first detection of anti-HEV IgA, IgM and IgG and seropositivity of the antibody classes. The diagnostic window between HEV RNA detection and first occurrence of anti-HEV antibodies ranged from eight to 48 days, depending on the serological assay used. The progression of laboratory parameters of asymptomatic HEV infection was largely comparable to the progression of symptomatic HEV infection, but only four of 10 donors showed elevated liver-specific parameters. Our results help elucidate the risk of transfusion-associated HEV infection and provide a basis for development of screening strategies. The diagnostic window illustrates that infectious blood donors can be efficiently identified only by RNA screening. European Centre for Disease Prevention and Control (ECDC) 2016-09-01 /pmc/articles/PMC5015460/ /pubmed/27608433 http://dx.doi.org/10.2807/1560-7917.ES.2016.21.35.30332 Text en This article is copyright of The Authors, 2016. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made.
spellingShingle Research Article
Vollmer, Tanja
Diekmann, Juergen
Eberhardt, Matthias
Knabbe, Cornelius
Dreier, Jens
Hepatitis E in blood donors: investigation of the natural course of asymptomatic infection, Germany, 2011
title Hepatitis E in blood donors: investigation of the natural course of asymptomatic infection, Germany, 2011
title_full Hepatitis E in blood donors: investigation of the natural course of asymptomatic infection, Germany, 2011
title_fullStr Hepatitis E in blood donors: investigation of the natural course of asymptomatic infection, Germany, 2011
title_full_unstemmed Hepatitis E in blood donors: investigation of the natural course of asymptomatic infection, Germany, 2011
title_short Hepatitis E in blood donors: investigation of the natural course of asymptomatic infection, Germany, 2011
title_sort hepatitis e in blood donors: investigation of the natural course of asymptomatic infection, germany, 2011
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5015460/
https://www.ncbi.nlm.nih.gov/pubmed/27608433
http://dx.doi.org/10.2807/1560-7917.ES.2016.21.35.30332
work_keys_str_mv AT vollmertanja hepatitiseinblooddonorsinvestigationofthenaturalcourseofasymptomaticinfectiongermany2011
AT diekmannjuergen hepatitiseinblooddonorsinvestigationofthenaturalcourseofasymptomaticinfectiongermany2011
AT eberhardtmatthias hepatitiseinblooddonorsinvestigationofthenaturalcourseofasymptomaticinfectiongermany2011
AT knabbecornelius hepatitiseinblooddonorsinvestigationofthenaturalcourseofasymptomaticinfectiongermany2011
AT dreierjens hepatitiseinblooddonorsinvestigationofthenaturalcourseofasymptomaticinfectiongermany2011